Psychedelics and Depression: What the Science Actually Shows
In 2021, researchers published the largest psilocybin trial ever conducted. The results reframed what we thought was possible in treating depression. Here is what they found, what came next, and what it means for the 100 million people worldwide who suffer from treatment-resistant forms of the illness.
Read article →
A Single Dose of Psilocybin Just Beat Cocaine Addiction. Here's How.
For fifty years, cocaine use disorder has had no approved medication. In May 2026, a randomized controlled trial published in JAMA Network Open changed that picture — not with a pharmaceutical, but with a single dose of psilocybin.
Read article →